Ian Tomlinson, Chair – Stevenage Bioscience Catalyst



Ian Tomlinson, Chair - Stevenage Bioscience Catalyst


DATE:
TIME:
VENUE:

Ian has 25+ years’ experience in life sciences, from academic research to biotech start-up to big pharma.  He founded Domantis with Sir Gregory Winter, acquired by GSK for $454m and was SVP, Head of Worldwide Business Development & Head of Biopharm R&D at GSK. Currently Chairman of Stevenage Bioscience Catalyst, the UK’s first open innovation biomedical campus; chair of the Investment Committee for Apollo Therapeutics, a £40m fund dedicated to turning academic biotechnologies into novel medicines.

Share Button